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We have isolated a portion of the canine gene enc~~ng the orphan receptor RDCl il]. The complete coding sequence is confined in a single exon. 
and an inlron divides the 5’ untranslated region of RDCl mRNA. The RDCi protein is 94% homologous to the gene product ofGPRN 1. which 
has been proposed to serve as a VIP receptor v&n expressed in CHO-ICI and COS-7 cells (Sreedharan, S.P. et al. (1901) Proc. Natl. Aold. Sci. 
USA ES, 498~99~). Noshes analysis indicates that CHO-K 1 cells endogenously express a 1.1 kb RDCI mRNA. However. while CHO-#I cells 
possess detcetabIe low affinity [‘251]VIP binding sites. VlP binding is not alters:d in membranes of CHO-Kl cells expressing varying amounts of 
the RDCI gene construct. Further, endogenous VIP binding is not increased by mnsient expression of RDCI in COS-7 c&s. Taken tog&cr. 
the data suggest that RDCl is not a canine honlo~og of the proposed VIP receptor. 
RLil: VIP receptor; Receptor expression; Receptor cloning: G-protein 
1. INTRODUCTION 
The putative G-protein-coupled orphan receptor 
RDCI was originally cloned from a dog thyroid cDNA 
IibCary [l], and its amino acid sequence has highest 
hoknology to receptors for pepticle ligands. While the 
RDCl sequence bears little similarity to the secretin 
receptor sequence [3], it shares a sequence identity widh 
a rccentiy cloned human VIP receptor of 91% and 94% 
at the nucleic acid and amino acid level, respectively [2]. 
The high degree of both nucleic acid and protein se- 
quence identity between the carine RDCI aad the 
human VlP receptor suggested that RDCI is the dog 
homolog of the proposed VIP receptor encoded by the 
GPRNI cDNA [2]. 
In searching for the l&and for RDCI and characteriz- 
ing this gene, we observed that the transcript was ubi- 
quitously expressed in clonal cell lines from a variety of 
~~~~~~llj~~fi~/~~~ YIP. vasoactive intestinal peplide: DMEM, Dulbccco’s 
modified Eagle medium: BSA, bovine serum albumin: fMLP, N- 
formyl-Mel-Leu-Phc; IL-& interleukin-M: IxSSPE, 0.1X M NaCl. 0.01 
M NaH$O,, pH 7.7.0.1 mM EDTA; WT. wild-type (untransfeclcdl 
ccli$: FBS. fetal bovine serum. 
C ,,~re~~~rr~r/[~nc’~ &/rt*.r.\: J.S. Roscnbaum. The Procter and Gdmhlc 
C’ompuny. Miami Valley taborutorics. P.0. Box 398707, Cincinn;~ti. 
OH 45239-8707. USA. Fax: (I) (513) 627 161”. 
lineages. In this communication we tested whether the 
RDCl construct encodes a canine VIP receptor when 
expressed in the CHO-K 1 and COS-7 cells used to clone 
the putative human VIP receptor [Z]. 
2. MATERIALS AND METHODS 
All enzymes were purchased from either Promega (Madison. WI) 
or Boehringer Man~heim (In~~iii~~polis. IN). [“‘l]VlP ~XOtl Cii 
mmol). [‘l-l]NMS (79 Ci/mmol). [y-“P]ATP. [I-“P]dCTP 
[a-‘iS]ATP 1 UC purLh.xml from New En&. Nuclear t tlostou. 
MA!. VIP was purchased from Bachem (Torrcnce. CA). 
CHO-KI cells (American Type Tissue Cuhurc (Rockville. MD)) 
were mzrintrtined in DMEM containing 5% FBS. C”OS-7 and HT29 
cells were maintarn~ cl in UMEM containing 10% FBS. 
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cloned G-protein-coupkd rercptors 
Tbc alignmmts were perfomaf using the prom FPAlTER- 
NALCGN (written by P-E. Cornea). The swpccted trdnsmcmbranc 
hetiil portions of the RDCl sequence were used as the pattern. Gaps 
were adjusted to optimize the alignments of the hydrophobic trans- 
mcmbranc domains. 
3. RESULTS AND DISCUSSION 
3. I. RDCI gene sequence and cmsrrrrcrs 
Comparison of the sequence of the published cDNA 
[I] and the PsrI genomic fragment revealed that the 
latter contained the complete coding sequence for Lhe 
RDCt protein, and an additional 601 bp preceding a 
potential intronlexon junction at 28 bp upstream of the 
initiation codon. This nov4 sequence: is characterized 
by multiple in-frame termination codons and a C+T- 
rich region preceding an AG at aase btiirs 602 + $3 
(corresponding to base pairs 43 + L4 of ~ili: GDNA 
sequence), indicating the location of an intron of at least 
601 bp in the 5’ untransIate.d region of the RDCl gene. 
The location of this intron is similar IO that found in the 
gene of another orphan G-protein-coupled receptor, 
RTA [I$ 
The 3’ untranslated region is charticterized by a palin- 
drtlrrk ( ATAAATAii sequence which extends for 63 
and 55 bp in the genomic and cDNA sequence. respec- 
ti~fy. Since A+T refpeats in the 3’ untranslated region 
arc thought to it#~n~ t&M.& gwhilit; [t ft wp &=a c-W--*-, I’*,. .I_ W..YIW 
10 dckte this putative destabilization seyucncc for !he 
expression erprrimcnts. 
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Fig. 2. Lack of ~~ter~ti~n i  end~ficno~s~‘~~l]Vl~ sptcilic binding with 
RDCI transfcction. A. Specific binding in CHO-K I cells. Binding was 
performed in mcmbranc homogcniltes from either WT ( !) or RDCI- 
transfcctcd cells its described in Methods. CWO-RDCI-6 (L) and 
CHO-RDCI-2 (0) exhibit an cnhtinccmcnt in RDCl mRNA exprcs- 
sion of 3- and 30.fold. rc~~~tjv~ly, in c~rn~~r~~~n to &at observed in 
cells not taking up the RDCl gem? fraymcnt (Fig. I). Dala rcpresenr 
the mean t SEM. for tripfictilc dclcrminations, Similar results wcrc 
obtained comparing cithcr WT and the two clones. or WT and CHO- 
RDCI-6, in one und three additional experiments, rcspcctivcly. 8. 
Specific binding in COS-7 cells. minding was ~rfo~~d in whole cells 
transfcctcd with cithcr nothing Ki) or RDCI (@I), ut IWO diffcrcnl 
(“~I]VIP concentrations 5s drscribed in se&ion 2. [‘HINMS binding 
(@i]l is illustrutcd as ii posilivc conlrol for trtlmfcctiufl (see sa;Linn 2). 
Data with [“‘I]VfPrcprcscnt illc mrar: ? S.D Stduplicalcdclcr;nina- 
tions. The ex~~m~nt was reprated once 4th simifar results. 
mRNA in 9 neomycin resistant CHO cell clones trans- 
&ted with the RRCl,,,J I,L)f, construct, and that of the 
original pool of CHO cell transfcctants. Two of these 
clones (CHO-RDCI-2 and CHO-RDCl-6; Fig. IA, 
lanes 3 and 7) showed an enhanced expression of 30- 
and 3-fold, respectively, when norm&cd to actin 
mRNA (Fig. IA and Is). Two diffcrcnt transcripts arc 
noticcabic in the RDCi transfcctunts with sizes aT 2.5 
and 2.1 kb resulting from the USC of alternate SV-40 
r~l;~c sites in the pCDNAI vector, Fig. IC compares 
the: cxprcssion of RDCf mRFrA in both the WT (un- 
transf’ccted) C’HO cells and the pool of CHO-RDCI ccl1 
tr~l~s~cct~~nts, A 2.1 kb RDCl mRNA is ~?bservcd in 
WT Cells (Fig. ICY). which corresponds to the mRNA 
observed in the neomycin resistant CHO cells that did 
not appear to express RDCl to a large extent (Fig. L%). 
A minor 2.3 kb RDCI mRNA was also observed in WT 
(XX-7 cells (data not shown). These data indicate that 
the RDCI gene is constituitively expressed in the two 
mammalian eeli types most commonly used for expres- 
sion and anafysis of G-protein-coupled receptors. 
3.3. [‘“Pf VIP Receptor &tiding in RDCI-transfected 
We investigated whether CHO-Kl and COS7 cells 
contained alow Ieve of endogenous VIP receptors. Fig. 
2A illustrates the [‘IsIjViP binding observed in 
membrane homogenates derived from WT and RDCl- 
transfected CHO-Kl cells. Specific binding is linear add 
does not saturate over the 2 nM concentration range. 
This low affinity binding is in contrast o the subnano- 
molar affinity in nerve cell lines [14] and lymphocyte 
[IS]. The low atlinity VIP binding sites may represent 
binding to other unrelated peptide receptors to which 
VIP has access [16]. 
A similar low level of [“‘I]VIP binding was observed 
in whole COS-7 cells (Fig. 28). In contrast, [“‘I]VlP 
biRding in HT29 cells was 20-fold higher { 10-12 fmol 
[“51]VIP bound/mg protein), as expected from previous 
results [8.9]. 
Endogenous birding was not increased in either cell 
line transfected with the RDcgene (Fig. 2A and 2B). 
Furthermore, VIP binding did not correlate with 
mRNA expressian and was identical in each of the 
CHO-Kl clones examined (Fig. IA and 2A). The 
pCDNAI vector was highly efTectivc in COS-7 cells as 
illustrated by the extensive cxprcssion with the trans- 
i&ted Hmt ~~us~~n~c re eptor (Fig. ZB and @]I. HOW- 
ever. a lack of RDC31 receptor antibody precludes our 
ability to reach a definitive conclusion regarding expres- 
sion of the RDCi protein in tither CHO-Kl or COS*7 
cells, ~everth~iess, when tab togetiter, the data indi- 
cate that RDCl does not appear to c;r:c-‘ic J ‘4 .I’ IC’- 
ccptor, 
Similar circumstances. i.e. low-a~nity binding and 
lack of correlation between binding and mRNA expres- 
sion, have resulted in the reassignment of the. identity 
of the F3R gene product. The F3R cDNA. originalfy 
~denti~ed asa rabbit fMLP receptor [17j. was sub%- 
quently identified as nn IL-8 receptor [18]; a result that 
was supported by its scquencc homology to mcmbcrs Of 
the IL-X receptor family [ 191. 
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